Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo

Oncology Reports

Volumn 24, Issue 5, 2010, Pages 1179-1184

  Wu, Yu Qing ^a   Song, Zheng ^a   Zhou, Cheng Hua ^a   Xing, Shu Hua ^a   Pei, Dong Sheng ^a   Zheng, Jun Nian ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

A549 cells; Lung adenocarcinoma; Nude mice; Urotensin II

Indexed keywords

MESSENGER RNA; UROTENSIN II; UROTENSIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; UROTENSINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78149290612     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000970     Document Type: Article

References (35)

1. Pearson D, Shively JE, Clark BR, Geschwind II, Barkley M, Nishioka RS and Bern HA: Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77: 5021-5024, 1980.
2. Coulouarn Y, Lihrmann I, Jegou S, et al: Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95: 15803-15808, 1998.
3. Elshourbagy NA, Douglas SA, Shabon U, et al: Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br J Pharmacol 136: 9-22, 2002.
4. Coulouarn Y, Jégou S, Tostivint H, Vaudry H and Lihrmann I: Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457: 28-32, 1999.
5. Ames RS, Sarau HM, Chambers JK, et al: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401: 282-286, 1999.
6. Davenport AP and Maguire JJ: Urotensin II: fish neuropeptide catches orphan receptor. Trends Pharmacol Sci 21: 80-82, 2000.
7. Camarda V, Rizzi A, Calò G, et al: Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents. Naunyn Schmiedebergs Arch Pharmacol 365: 141-149, 2002.
8. Douglas SA, Sulpizio AC, Piercy V, et al: Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 131: 1262-1274, 2000.
9. Katano Y, Ishihata A, Aita T, Ogaki T and Horie T: Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries. Eur J Pharmacol 402: R5-R7, 2000.
10. Gardiner SM, March JE, Kemp PA, Davenport AP and Bennett T: Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br J Pharmacol 132: 1625-1629, 2001.
11. Russell FD, Molenaar P and O'Brien DM: Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol 132: 5-9, 2001.
12. Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P and Loirand G: Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88: 1102-1104, 2001.
13. Watanabe T, Pakala R, Katagiri T and Benedict CR: Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104: 16-18, 2001.
14. Watanabe T, Pakala R, Katagiri T and Benedict CR: Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation. J Hypertens 19: 2191-2196, 2001. (Pubitemid 33135241)
15. Silvestre RA, Rodríguez-Gallardo J, Egido EM and Marco J: Inhibition of insulin release by urotensin II, a study on the perfused rat pancreas. Horm Metab Res 33: 379-381, 2001.
16. Takahashi K, Totsune K, Murakami O and Shibahara S: Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells. Peptides 22: 1175-1179, 2001.
17. Morimoto R, Satoh F, Murakami O, et al: Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues. Peptides 29: 873-880, 2008. (Pubitemid 351522359)
18. Takahashi K, Totsune K, Murakami O, Arihara Z, Noshiro T, Hayashi Y and Shibahara S: Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II. Peptides 24: 301-306, 2003.
19. Shenouda A, Douglas SA, Ohlstein EH and Giaid A: Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma. J Histochem Cytochem 50: 885-889, 2002.
20. Zeng ZP, Liu GQ, Li HZ, et al: The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues. Ann N Y Acad Sci 1073: 284-289, 2006.
21. Giuliani L, Lenzini L, Antonello M, et al: Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism. J Clin Endocrinol Metab 94: 684-690, 2009.
22. Shi J, Zheng D, Liu Y, Sham MH, Tam P, Farzaneh F and Xu R: Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res 65: 1687-1692, 2005.
23. Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N and Hirata Y: Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19: 2185-2190, 2001.
24. Deprez-Roy I, Coge F, Bertry L, Galizzi JP, Feletou M, Vanhoutte PM and Canet E: Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cells. Acta Pharmacol Sin 21: , 2000.
25. Ahmed SI, Thompson J, Coulson JM and Woll PJ: Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol 22: 422-431, 2000.
26. Uchida K, Kojima A, Morokawa N, et al: Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer. J Cancer Res Clin Oncol 128: 633-640, 2002.
27. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA and Giese NA: Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 62: 3729-3735, 2002.
28. Imai N, Hashimoto T, Kihara M, et al: Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis. Lab Invest 87: 189-198, 2007.
29. Asham E, Shankar A, Loizidou M, et al: Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br J Cancer 85: 1759-1763, 2001.
30. Tsai CS, Loh SH, Liu JC, Lin JW, Chen YL, Chen CH and Cheng TH: Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Atherosclerosis 206: 86-94, 2009.
31. Liu JC, Chen CH, Chen JJ and Cheng TH: Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor. Mol Pharmacol 76: 1186-1195, 2009.
32. Zhang Y, Li Y, Wei R, et al: Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat. Regul Pept 151: 88-94, 2008.
33. Matsushita M, Shichiri M, Fukai N, Ozawa N, Yoshimoto T, Takasu N and Hirata Y: Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 144: 1825-1831, 2003.
34. Onan D, Pipolo L, Yang E, Hannan RD and Thomas WG: Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases. Mol Endocrinol 18: 2344-2354, 2004.
35. Watanabe T, Takahashi K, Kanome T, et al: Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide. Hypertens Res 29: 821-831, 2006.